Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31065657 | 0.98 | LMNA (0.48) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL366646 | 0.98 | TSHR (0.48) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL19135584 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL10460696 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL28930080 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL25121223 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL14515882 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL28191745 | 0.95 | LMNA (0.50) | TSHRLMNAALDH1A1TDP1DNM1 | |
| SCHEMBL30818337 | 0.91 | LMNA (0.46) | TSHRLMNADNM1OPRM1FDPS | |
| SCHEMBL6718168 | 0.91 | TSHR (0.46) | TSHRLMNAALDH1A1TDP1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1954668-B9 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-1954668-B1 | HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2011-09-28 | — | — | EP | disclosed |
| WO-2007062314-A2 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| US-5236900-A | Treating Candida infections | SCHERING CORPORATION (US) | 1993-08-17 | — | — | US | disclosed |